BRIEF published on 10/30/2024 at 12:20, 21 days 21 hours ago Applied DNA Sciences lève 6,5 millions de dollars grâce à une offre directe et un placement privé Placement Privé Craig Hallum Offre Directe Technologies De L'ADN Bons De Souscription De Séries C Et D
BRIEF published on 10/30/2024 at 12:20, 21 days 21 hours ago Applied DNA Sciences Raises $6.5 Million Through Direct Offering and Private Placement Private Placement DNA Technologies Direct Offering Series C And D Warrants Craig-Hallum
PRESS RELEASE published on 10/30/2024 at 12:15, 21 days 21 hours ago Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement Applied DNA Sciences, Inc. announces the pricing of a $6.5 million registered direct offering and concurrent private placement to develop Therapeutic DNA Production Services Private Placement Registered Direct Offering Applied DNA Sciences DNA Technologies Therapeutic DNA Production Services
BRIEF published on 10/15/2024 at 16:35, 1 month 5 days ago Applied DNA participera au sommet virtuel Maxim Healthcare 2024 Biotechnologie ADN Appliqué James A. Hayward Sommet Maxim Sur Les Soins De Santé Technologies PCR ADN
BRIEF published on 10/15/2024 at 16:35, 1 month 5 days ago Applied DNA to Participate in Maxim Healthcare Virtual Summit 2024 Biotechnology Applied DNA Maxim Healthcare Summit PCR DNA Technologies James A. Hayward
PRESS RELEASE published on 10/15/2024 at 16:30, 1 month 5 days ago Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16 Applied DNA Sciences to participate in Maxim Healthcare Virtual Summit with CEO Dr. James A. Hayward in a fireside chat on October 16, 2024. Company overview and business focus detailed Biotechnology Company Applied DNA Sciences PCR-based DNA Technologies Maxim Healthcare Virtual Summit CEO Interview
BRIEF published on 09/18/2024 at 15:05, 2 months 2 days ago Applied DNA retrouve sa conformité avec l'exigence de prix d'offre minimum du Nasdaq Bourse Conformité Au Nasdaq ADN Appliqué Prix De L'offre Technologies Basées Sur La PCR
BRIEF published on 09/18/2024 at 15:05, 2 months 2 days ago Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement Nasdaq Compliance Stock Market Bid Price Applied DNA PCR-based Technologies
PRESS RELEASE published on 09/18/2024 at 15:00, 2 months 2 days ago Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement Applied DNA Sciences, Inc. regains compliance with Nasdaq minimum bid price requirement. Full details on the company's PCR-based DNA technologies and markets Biotechnology Forward-looking Statements Nasdaq Compliance Applied DNA Sciences PCR-based DNA
BRIEF published on 09/17/2024 at 15:20, 2 months 3 days ago Applied DNA Presents Linea IVT Platform at mRNA Summit Applied DNA Sciences Linea IVT Platform MRNA Summit Kudo Biotechnology DsRNA Mitigation
Published on 11/21/2024 at 09:00, 37 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 2 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 12 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 37 minutes ago Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 37 minutes ago Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates
Published on 11/21/2024 at 08:59, 37 minutes ago Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 37 minutes ago Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 22 minutes ago EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 28 minutes ago KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024
Published on 11/21/2024 at 06:58, 2 hours 39 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 39 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 39 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 30 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 17 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
